• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 7 Jan

    Brigadier General Barry L. Shoop Appointed to Bubblr Advisory Board

    BBLR-stockmarket-investment-microcaps

    Shoop’s Leadership Experience Bridges Military, Academia, Industry and Not-for-Profit Sectors During Distinguished 40-Year Career London, UK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Bubblr Inc., (OTC PINK: BBLR), ("Bubblr" or the "Company"), an ethical technology company focused on the development and commercialization of mobile-first technologies, today announced the… Read More..

    Share this:
  • 7 Jan

    Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma

    SNGX biopharma stockmarket smallcaps microcaps investments

    -- Providing an end-to-end business solution for our customers -- Ensuring seamless integration of drug and light combination for both physicians and patients PRINCETON, N.J., Jan. 7, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat… Read More..

    Share this:
  • 5 Jan

    Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 – 14, 2021

    Arch Therapeutics #stock #investments #smallcap

    FRAMINGHAM, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021. Chief Executive Officer, Terrence… Read More..

    Share this:
« Previous 1 … 118 119 120 121 122 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact